Reduction of antimalarial antibodies by HIV infection is associated with increased risk of plasmodium falciparum cord blood infection

Journal of Infectious Diseases

Volumn 205, Issue 4, 2012, Pages 568-577

  Naniche, Denise ^a,b   Serra Casas, Elisa ^a   Bardají, Azucena ^a,b   Quintó, Lloren ^a   Dobaño, Carlota ^a,b   Sigauque, Betuel ^b,c   Cisteró, Pau ^a   Chauhan, Virander S ^d   Chitnis, Chetan E ^d   Alonso, Pedro L ^a,b   Menéndez, Clara ^a,b   Mayor, Alfredo ^a,b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Manhiça Health Research Center   (Mozambique)

^c INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHONDROITIN 4 SULFATE; ERYTHROCYTE BINDING ANTIGEN 175; IMMUNOGLOBULIN G; NEVIRAPINE; PLACEBO; PLASMODIUM FALCIPARUM ANTIBODY; PROTOZOON ANTIBODY; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; DRUG INTERMITTENT THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MOZAMBIQUE; PARASITE TRANSMISSION; PLACENTAL MALARIA; PLASMODIUM FALCIPARUM CORD BLOOD INFECTION; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; YOUNG ADULT;

EID: 84856275049     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir815     Document Type: Article

References (44)

1. Schwetz J, Peel M. Congenital malaria and placental infections amongst the negroes of Central Africa. Trans R Soc Trop Med Hyg 1934; 28: 167-74.
2. Menendez C, Mayor A. Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med 2007; 12: 207-13. (Pubitemid 46680526)
3. Redd SC, Wirima JJ, Steketee RW, Breman JG, Heymann DL. Transplacental transmission of Plasmodium falciparum in rural Malawi. Am J TropMed Hyg 1996; 55:57-60.
4. Menendez C, Bardaji A, Sigauque B, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One 2010; 5:e9438.
5. Ndyomugyenyi R,Magnussen P. Chloroquine prophylaxis, iron-folic acid supplementation or case management of malaria attacks in primigravidae in western Uganda: effects on maternal parasitaemia and haemoglobin levels and on birthweight. Trans R Soc Trop Med Hyg 2000; 94: 413-8.
6. Villamor E, Msamanga G, Aboud S, Urassa W, Hunter DJ, Fawzi WW. Adverse perinatal outcomes of HIV-1-infected women in relation to malaria parasitemia in maternal and umbilical cord blood. Am J Trop Med Hyg 2005; 73:694-7. (Pubitemid 41446715)
7. Malhotra I, Dent A, Mungai P, et al. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med 2009; 6:e1000116.
8. Fischer PR. Malaria and newborns. J Trop Pediatr 2003; 49:132-4. (Pubitemid 36789798)
9. Falade C, Mokuolu O, Okafor H, et al. Epidemiology of congenital malaria in Nigeria: a multi-centre study. Trop Med Int Health 2007; 12: 1279-87. (Pubitemid 350191140)
10. Okafor UH, Oguonu T, Onah HE. Risk factors associated with congenital malaria in Enugu, South Eastern Nigeria. J Obstet Gynaecol 2006; 26:612-6. (Pubitemid 44663870)
11. Malhotra I, Mungai P, Muchiri E, Kwiek JJ, Meshnick SR, King CL. Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya. J Infect Dis 2006; 194:176-83. (Pubitemid 44087188)
12. Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol 2000; 31:85-93. (Pubitemid 30054392)
13. Ter Kuile FO, Parise ME, Verhoeff FH, et al. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 2004; 71:41-54. (Pubitemid 39121303)
14. Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-9.
15. Verhoeff FH, Brabin BJ, Hart CA, Chimsuku L, Kazembe P, Broadhead RL. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. Trop Med Int Health 1999; 4:5-12. (Pubitemid 29081212)
16. Perrault SD, Hajek J, Zhong K, et al. Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in western Kenya. Am J Trop Med Hyg 2009; 80:119-25.
17. Ayisi JG, Branch OH, Rafi-Janajreh A, et al. Does infection with human immunodeficiency virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect 2003; 46:164-72. (Pubitemid 36395304)
18. Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 2004; 363:1860-7. (Pubitemid 38748641)
19. Van Geertruyden JP, Van Eijk E, Yosaatmadja F, et al. The relationship of Plasmodium falciparum humeral immunity with HIV-1 immunosuppression and treatment efficacy in Zambia. Malar J 2009; 8:258.
20. Wabwire-Mangen F, Gray RH,Wawer MJ, Sewankambo N, Serwadda D. HIV-1 infection and malaria parasitaemia. Lancet 2001; 357:233.
21. Menendez C, Bardaji A, Sigauque B, et al. A randomized placebocontrolled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008; 3:e1934.
22. Ordi J, Ismail MR, Ventura PJ, et al. Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol 1998; 22:1006-11. (Pubitemid 28364501)
23. Alonso PL, Smith T, Schellenberg JR, et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1994; 344:1175-81. (Pubitemid 24323705)
24. Mayor A, Serra-Casas E, Bardaji A, et al. Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar J 2009; 8:9.
25. Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Bioprocess Biosyst Eng 2010; 33:719-30.
26. Pandey KC, Singh S, Pattnaik P, et al. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 2002; 123:23-33. (Pubitemid 34880088)
27. Kocken CH, Withers-Martinez C, Dubbeld MA, et al. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect Immun 2002; 70:4471-6. (Pubitemid 34790958)
28. Serra-Casas E, Menendez C, Bardaji A, et al. The effect of intermittent preventive treatment during pregnancy on malarial antibodies depends on HIV status and is not associated with poor delivery outcomes. J Infect Dis 2010; 201:123-31.
29. Menendez C, Serra-Casas E, Scahill MD, et al. HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment. Clin Infect Dis 2011; 52:41-8.
30. Mayor A, Rovira-Vallbona E, Machevo S, et al. Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Infect Immun 2011; 79:1654-9.
31. Muema DK, Ndungu FM, Kinyanjui SM, Berkley JA. Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study. Malar J 2011; 10:55.
32. Mwangoka GW, Kimera SI, Mboera LE. Congenital Plasmodium falciparum infection in neonates in Muheza District, Tanzania. Malar J 2008; 7:117.
33. Sotimehin SA, Runsewe-Abiodun TI, Oladapo OT, Njokanma OF, Olanrewaju DM. Possible risk factors for congenital malaria at a tertiary care hospital in Sagamu, Ogun State, south-west Nigeria. J Trop Pediatr 2008; 54:313-20.
34. De Silva DH, Mendis KN, Premaratne UN, Jayatilleke SM, Soyza PE. Congenital malaria due to Plasmodium vivax: a case report from Sri Lanka. Trans R Soc Trop Med Hyg 1982; 76:33-5.
35. Dembo EG, Mwapasa V, Montgomery J, et al. Impact of human immunodeficiency virus infection in pregnant women on variantspecific immunity to malaria. Clin Vaccine Immunol 2008; 15: 617-21. (Pubitemid 351967052)
36. Jaworowski A, Fernandes LA, Yosaatmadja F, et al. Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria. Clin Vaccine Immunol 2009; 16:312-9.
37. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccinepreventable diseases in uninfected infants. JAMA 2011; 305:576-84.
38. De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6. (Pubitemid 38326236)
39. Titanji K, De Milito A, Cagigi A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7. (Pubitemid 44316125)
40. Tobian AA, Mehlotra RK, Malhotra I, et al. Frequent umbilical cordblood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J Infect Dis 2000; 182:558-63. (Pubitemid 30651054)
41. Naniche D, Bardaji A, Lahuerta M, et al. Impact of maternal human immunodeficiency virus infection on birth outcomes and infant survival in rural Mozambique. Am J Trop Med Hyg 2009; 80:870-6.
42. Perez-Hoyos S, Naniche D, Macete E, et al. Stabilization of HIV incidence in women of reproductive age in southern Mozambique. HIV Med 2011; 12:500-5.
43. Feng G, Simpson JA, Chaluluka E, Molyneux ME, Rogerson SJ. Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. PLoS One 2010; 5:e12012.
44. World Health Organization. World malaria report. Geneva: World Health Organization, 2010.